ESC Professional Premium Access

Decreased device related thrombus and enhanced neo-endocardial tissue maturation with a new generation left atrial appendage closure (LAAC) device. An anticoagulation and antiplatelet free canin study

Congress Presentation

About the speaker

Doctor Walid Saliba

Cleveland Clinic Foundation, Cleveland (United States of America)
0 follower

4 more presentations in this session

Risk of stroke and transient ischemic attack after elective cardioversion of atrial fibrillation: A nationwide study in Finland

Speaker: Mrs S. Itainen-Stromberg (Helsinki, FI)


Clinical risk prediction for left atrial appendage thrombus among patients with atrial fibrillation

Speaker: Professor P. Kistler (Melbourne, AU)


Left atrial appendage occlusion versus standard of care in patients with atrial fibrillation and a prior thrombo-embolic event despite oral anticoagulant therapy: a propensity score matched comparison

Speaker: Professor L. Boersma (Nieuwegein, NL)


Impact of ABC pathway adherence in high-risk patients with atrial fibrillation: an analysis from the ESC-EHRA EORP-AF long-term general registry

Speaker: Doctor W. Ding (Liverpool, GB)


Access the full session

Stroke prevention by anticoagulation and appendage occlusion in atrial fibrillation

Speakers: Doctor W. Saliba, Mrs S. Itainen-Stromberg, Professor P. Kistler, Professor L. Boersma, Doctor W. Ding

About the event


ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb